Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0013030,
umls-concept:C0030685,
umls-concept:C0032181,
umls-concept:C0232105,
umls-concept:C0391871,
umls-concept:C0443286,
umls-concept:C0456389,
umls-concept:C0574032,
umls-concept:C0680255,
umls-concept:C0681850,
umls-concept:C0857121,
umls-concept:C1280500,
umls-concept:C1283071,
umls-concept:C1550501,
umls-concept:C1706203,
umls-concept:C1963578,
umls-concept:C2349001,
umls-concept:C2697811
|
pubmed:issue |
4
|
pubmed:dateCreated |
1989-8-10
|
pubmed:abstractText |
To examine the effect of dopamine on in vivo platelet function and a possible platelet contribution to the clearance of dopamine we measured platelet count, platelet size and plasma concentration of the platelet specific protein beta-thromboglobulin (BTG) in groups of 40 year old untreated hypertensive and normotensive men. One hypertensive (n = 10) and one normotensive (n = 10) group received dopamine infusion at doses from 0.5 to 2.0 micrograms/kg/min which increased plasma dopamine 100-fold from baseline. Two other groups of hypertensive (n = 10) and normotensive (n = 11) subjects received 10 mg of the dopamine antagonist metoclopramide intravenously, upon which serum prolactin concentration increased 10-fold. No significant effect on platelet function in any group was observed during these interventions. Platelet phenol-sulphotransferase may contribute to dopamine conjugation. However, the selected platelet parameters correlated only weakly with dopamine kinetics during the infusion. Neither dopamine nor a dopamine antagonist altered the selected platelet parameters, nor did these parameters influence the clearance of dopamine during a short-lasting pharmacological infusion.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0036-5513
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
49
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
307-15
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2525805-Blood Platelets,
pubmed-meshheading:2525805-Dopamine,
pubmed-meshheading:2525805-Humans,
pubmed-meshheading:2525805-Hypertension,
pubmed-meshheading:2525805-Infusions, Intravenous,
pubmed-meshheading:2525805-Male,
pubmed-meshheading:2525805-Metoclopramide,
pubmed-meshheading:2525805-Platelet Count,
pubmed-meshheading:2525805-Prolactin,
pubmed-meshheading:2525805-Receptors, Dopamine,
pubmed-meshheading:2525805-beta-Thromboglobulin
|
pubmed:year |
1989
|
pubmed:articleTitle |
Effect of dopamine and dopamine-antagonist infusion on blood platelet count, size and release reaction in hypertensive and normotensive subjects.
|
pubmed:affiliation |
Department of Internal Medicine, Oslo University Medical School, Ullevaal Hospital, Norway.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|